Teacher Retirement System of Texas Portfolio holdings
AUM
$23.8B
1-Year Return
25.15%
This Quarter Return
+13.64%
1 Year Return
+25.15%
3 Year Return
+104.39%
5 Year Return
+185.58%
10 Year Return
+422.47%
AUM
$23.8B
AUM Growth
-$151M
(-0.63%)
Cap. Flow
-$2.55B
Cap. Flow
% of AUM
-10.71%
Top 10 Holdings %
Top 10 Hldgs %
25.9%
Holding
2,140
New
63
Increased
1,173
Reduced
814
Closed
86
Top Buys
| 1 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$385M |
| 2 |
AutoZone
AZO
|
+$62M |
| 3 |
Palo Alto Networks
PANW
|
+$36.4M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$33.8M |
| 5 |
Cigna
CI
|
+$29.4M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.29B |
| 2 |
iShares MSCI India ETF
INDA
|
+$213M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$107M |
| 4 |
NVIDIA
NVDA
|
+$71.5M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$69.9M |
Sector Composition
| 1 | Technology | 27.71% |
| 2 | Financials | 11.99% |
| 3 | Consumer Discretionary | 11.07% |
| 4 | Healthcare | 10.55% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Sotera Health
SHC
$4.49B
| $264K | ﹤0.01% |
23,707
+933
| +4% | +$10.4K |
|
1827
Apogee Therapeutics
APGE
$2.26B
| $261K | ﹤0.01% |
6,013
-47
| -0.8% | -$2.04K |
|
1828
Harrow
HROW
$1.48B
| $259K | ﹤0.01% |
8,478
+332
| +4% | +$10.1K |
|
1829
Ocular Therapeutix
OCUL
$2.22B
| $258K | ﹤0.01% |
27,799
+2,417
| +10% | +$22.4K |
|
1830
Werner Enterprises
WERN
$1.65B
| $257K | ﹤0.01% |
9,403
+368
| +4% | +$10.1K |
|
1831
Collegium Pharmaceutical
COLL
$1.19B
| $256K | ﹤0.01% |
8,661
-19
| -0.2% | -$562 |
|
|
BRKL
1832
DELISTED
Brookline Bancorp
BRKL
| $256K | ﹤0.01% |
24,245
+35
| +0.1% | +$369 |
|
1833
Janux Therapeutics
JANX
$1.52B
| $256K | ﹤0.01% |
11,068
+137
| +1% | +$3.17K |
|
|
HTO
1834
H2O America Common Stock
HTO
$1.74B
| $256K | ﹤0.01% |
4,918
+304
| +7% | +$15.8K |
|
1835
Enovix
ENVX
$1.95B
| $254K | ﹤0.01% |
28,121
+1,527
| +6% | +$13.8K |
|
1836
Donnelley Financial Solutions
DFIN
$1.51B
| $254K | ﹤0.01% |
+4,120
| New | +$254K |
|
1837
RXO
RXO
$2.75B
| $254K | ﹤0.01% |
16,154
+892
| +6% | +$14K |
|
1838
Central Garden & Pet Class A
CENTA
$2.07B
| $253K | ﹤0.01% |
8,088
+304
| +4% | +$9.51K |
|
1839
Kiniksa Pharmaceuticals
KNSA
$2.67B
| $253K | ﹤0.01% |
9,144
-918
| -9% | -$25.4K |
|
1840
Ardelyx
ARDX
$1.57B
| $252K | ﹤0.01% |
64,236
+497
| +0.8% | +$1.95K |
|
1841
Liberty Global Class A
LBTYA
$3.94B
| $251K | ﹤0.01% |
25,059
-4,820
| -16% | -$48.2K |
|
1842
Materion
MTRN
$2.29B
| $251K | ﹤0.01% |
3,160
+126
| +4% | +$10K |
|
1843
Intellia Therapeutics
NTLA
$1.25B
| $249K | ﹤0.01% |
26,499
+458
| +2% | +$4.3K |
|
1844
Adient
ADNT
$1.91B
| $248K | ﹤0.01% |
12,769
+340
| +3% | +$6.62K |
|
1845
Crescent Energy
CRGY
$2.19B
| $248K | ﹤0.01% |
28,860
+3,092
| +12% | +$26.6K |
|
1846
AtriCure
ATRC
$1.75B
| $246K | ﹤0.01% |
7,512
+385
| +5% | +$12.6K |
|
1847
Novavax
NVAX
$1.3B
| $246K | ﹤0.01% |
39,020
+218
| +0.6% | +$1.37K |
|
1848
Hanesbrands
HBI
$2.21B
| $246K | ﹤0.01% |
53,616
+2,091
| +4% | +$9.58K |
|
1849
Kirby Corp
KEX
$4.86B
| $245K | ﹤0.01% |
2,162
+62
| +3% | +$7.03K |
|
1850
CONMED
CNMD
$1.64B
| $245K | ﹤0.01% |
4,696
+181
| +4% | +$9.43K |
|